Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INFILTRATING LYMPHOCYTES' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1764 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Domagala-Kulawik, J; Hoser, G; Droszcz, P; Kawiak, J; Droszcz, W; Chazan, R
      T-cell subtypes in bronchoalveolar lavage fluid and in peripheral blood from patients with primary lung cancer

      DIAGNOSTIC CYTOPATHOLOGY
    2. Lang, S; Zeidler, R; Pauli, C; Andratschke, M; Wollenberg, B
      Targeting head and neck cancer by IL-2-mediated gene therapy: From bench to bedside - A review.

      LARYNGO-RHINO-OTOLOGIE
    3. Qin, HZ; Valentino, J; Manna, S; Tripathi, PK; Bhattacharya-Chatterjee, M; Foon, KA; O'Malley, BW; Chatterjee, SK
      Gene therapy for head and neck cancer using vaccinia virus expressing IL-2in a murine model, with evidence of immune suppression

      MOLECULAR THERAPY
    4. Tanigawa, K; Takeshita, N; Eickhoff, GA; Shimizu, K; Chang, AE
      Antitumor reactivity of lymph node cells primed in vivo with dendritic cell-based vaccines

      JOURNAL OF IMMUNOTHERAPY
    5. Harada, M; Li, YF; El-Gamil, M; Ohnmacht, GA; Rosenberg, SA; Robbins, PF
      Melanoma-reactive CD8(+) T cells recognize a novel tumor antigen expressedin a wide variety of tumor types

      JOURNAL OF IMMUNOTHERAPY
    6. Dudley, ME; Wunderlich, J; Nishimura, MI; Yu, D; Yang, JC; Topalian, SL; Schwartzentruber, DJ; Hwu, P; Marincola, FM; Sherry, R; Leitman, SF; Rosenberg, SA
      Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

      JOURNAL OF IMMUNOTHERAPY
    7. Zeng, G
      MHC class II-restricted tumor antigens recognized by CD4(+) T cells: New strategies for cancer vaccine design

      JOURNAL OF IMMUNOTHERAPY
    8. Riley, JP; Rosenberg, SA; Parkhurst, MR
      Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase

      JOURNAL OF IMMUNOTHERAPY
    9. Sugiyama, Y; Kato, M; Chen, FA; Williams, SS; Kawaguchi, Y; Miya, K; Jong, YS; Mathiowitz, E; Egilmez, NK; Bankert, RB
      Human inflammatory cells within the tumor microenvironment of lung tumor xenografts mediate tumor growth suppression in situ that depends on and is augmented by interleukin-12

      JOURNAL OF IMMUNOTHERAPY
    10. Lau, R; Wang, F; Jeffery, G; Marty, V; Kuniyoshi, J; Bade, E; Ryback, ME; Weber, J
      Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma

      JOURNAL OF IMMUNOTHERAPY
    11. Dobrzanski, MJ; Reome, JB; Dutton, RW
      Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cell-mediated tumor rejection

      CLINICAL IMMUNOLOGY
    12. Zhang, XY; Chan, WY; Whitney, BM; Fan, DM; Chow, JHS; Liu, Y; Ng, EKW; Chung, SCS
      T cell receptor V beta repertoire expression reflects gastric carcinoma progression

      CLINICAL IMMUNOLOGY
    13. Bankert, RB; Egilmez, NK; Hess, SD
      Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies

      TRENDS IN IMMUNOLOGY
    14. Wang, RF
      The role of MHC class II-restricted tumor antigens and CD4(+) T cells in antitumor immunity

      TRENDS IN IMMUNOLOGY
    15. Nawrocki, S; Wysocki, PJ; Mackiewicz, A
      Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer

      EXPERT OPINION ON BIOLOGICAL THERAPY
    16. Wang, E; Phan, GQ; Marincola, FM
      T-cell-directed cancer vaccines: the melanoma model

      EXPERT OPINION ON BIOLOGICAL THERAPY
    17. Albertini, MR; King, DM; Newton, MA; Vacek, PM
      In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    18. Csiszar, A; Szentes, T; Haraszti, B; Zou, WP; Emilie, D; Petranyi, G; Pocsik, E
      Characterization of cytokine mRNA expression in tumour-infiltrating mononuclear cells and tumour cells freshly isolated from human colorectal carcinomas

      EUROPEAN CYTOKINE NETWORK
    19. Lamana, ML; Segovia, JC; Guenechea, G; Bueren, JA
      Systematic analysis of clinically applicable conditions leading to a high efficiency of transduction and transgene expression in human T cells

      JOURNAL OF GENE MEDICINE
    20. Murakami, Y; Kanda, K; Yokota, KY; Kanayama, HO; Kagawa, S
      Prognostic significance of immuno-proteosome subunit expression in patients with renal-cell carcinoma: A preliminary study

      MOLECULAR UROLOGY
    21. Kummar, S; Ishii, A; Yang, HK; Venzon, DJ; Kim, SJ; Gress, RE
      Modulation of graft-versus-tumor effects in a murine allogeneic bone marrow transplantation model by tumor-derived transforming growth factor-beta 1

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    22. Yamshchikov, G; Thompson, L; Ross, WG; Galavotti, H; Aquila, W; Deacon, D; Caldwell, J; Patterson, JW; Hunt, DF; Slingluff, CL
      Analysis of a natural immune response against tumor antigens in a melanomasurvivor: Lessons applicable to clinical trial evaluations

      CLINICAL CANCER RESEARCH
    23. Clemons-Miller, AR; Chatta, GS; Hutchins, L; Angtuaco, EJ; Ravaggi, A; Santin, AD; Cannon, MJ
      Intrathecal cytotoxic T-cell immunotherapy for metastatic leptomeningeal melanoma

      CLINICAL CANCER RESEARCH
    24. Finke, JH; Rayman, P; George, R; Tannenbaum, CS; Kolenko, V; Uzzo, R; Novick, AC; Bukowski, RM
      Tumor-induced sensitivity to apoptosis in T cells from patients with renalcell carcinoma: Role of nuclear factor-kappa B suppression

      CLINICAL CANCER RESEARCH
    25. Mailliard, RB; Lotze, MT
      Dendritic cells prolong tumor-specific T-cell survival and effector function after interaction with tumor targets

      CLINICAL CANCER RESEARCH
    26. Tong, AW; Papayoti, MH; Netto, G; Armstrong, DT; Ordonez, G; Lawson, JM; Stone, MJ
      Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer

      CLINICAL CANCER RESEARCH
    27. Quesnel, A; Zerbib, A; Connan, F; Guillet, JG; Briand, JP; Choppin, J
      Synthesis and antigenic properties of reduced peptide bond analogues of animmunodominant epitope of the melanoma MART-1 protein

      JOURNAL OF PEPTIDE SCIENCE
    28. Porter, GA; Abdalla, J; Lu, MS; Smith, S; Montgomery, D; Grimm, E; Ross, MI; Mansfield, PF; Gershenwald, JE; Lee, JE
      Significance of plasma cytokine levels in melanoma patients with histologically negative sentinel lymph nodes

      ANNALS OF SURGICAL ONCOLOGY
    29. Belldegrun, A; Tso, CL; Zisman, A; Naitoh, J; Said, J; Pantuck, AJ; Hinkel, A; de Kernion, J; Figlin, R
      Interleukin 2 gene therapy for prostate cancer: Phase I clinical trial andbasic biology

      HUMAN GENE THERAPY
    30. Okada, H; Lunsford, LD; Kondziolka, D; Schiff, D; Pollack, I; Lieberman, F; Edington, H
      Gene therapy of malignant gliomas: A pilot study of vaccination with irradiated autologous glioma and dendritic cells admired with IL-4 transduced fibroblasts to elicit an immune response

      HUMAN GENE THERAPY
    31. Kaufman, HL; DeRaffele, G; Divito, J; Horig, H; Lee, D; Panicali, D; Voulo, M
      A phase I trial of intralesional rV-Tricom vaccine in the treatment of malignant melanoma

      HUMAN GENE THERAPY
    32. Godley, PA; Taylor, M
      Renal cell carcinoma

      CURRENT OPINION IN ONCOLOGY
    33. Weber, JS; Aparicio, A
      Novel immunologic approaches to the management of malignant melanoma

      CURRENT OPINION IN ONCOLOGY
    34. Hayes, RL; Arbit, E; Odaimi, M; Pannullo, S; Scheff, R; Kravchinskiy, D; Zaroulis, C
      Adoptive cellular immunotherapy for the treatment of malignant gliomas

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    35. Hobeika, AC; Clay, TM; Mosca, PJ; Lyerly, HK; Morse, MA
      Quantitating therapeutically relevant T-cell responses to cancer vaccines

      CRITICAL REVIEWS IN IMMUNOLOGY
    36. Yutani, S; Shichijo, S; Inoue, Y; Kawagoe, N; Okuda, K; Kurohiji, T; Tanaka, M; Sata, M; Itoh, K
      Expression of the SART1 tumor-rejection antigen in hepatocellular carcinomas

      ONCOLOGY REPORTS
    37. Zusman, I; Gurevich, P; Gurevich, E; Ben-Hur, H
      The immune system, apoptosis and apoptosis-related proteins in human ovarian tumors (A review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    38. Chen, J; Niu, HT; He, W; Ba, DN
      Antitumour activity of expanded human tumor-infiltrating gamma delta T lymphocytes

      INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    39. Cai, JL; Tucker, PW
      Gamma-delta T cells: Immunoregulatory functions and immunoprotection

      GAMMA-DELTA T CELLS
    40. Lu, Y; Yamauchi, N; Koshita, Y; Fujiwara, H; Sato, Y; Fujii, S; Takahashi, M; Sato, T; Kato, J; Yamagishi, H; Niitsu, Y
      Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule

      GENE THERAPY
    41. Wang, Q; Yu, H; Ju, DW; He, L; Pan, JP; Xia, DJ; Zhang, LH; Cao, X
      Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma

      GENE THERAPY
    42. Rosenberg, SA
      Progress in the development of immunotherapy for the treatment of patientswith cancer

      JOURNAL OF INTERNAL MEDICINE
    43. Salih, HR; Nussler, V
      Commentary: Immune escape versus tumor tolerance: How do tumors evade immune surveillance?

      EUROPEAN JOURNAL OF MEDICAL RESEARCH
    44. Oliveira, JGG; Ramos, JP; Xavier, P; Sampaio, S; Magalhaes, MC; Mendes, AA; Pestana, M
      Microemulsion cyclosporin formulation, in contrast to the old formulation,widens the T lymphocyte subsets differences between stable and acute rejection of kidney transplants

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    45. Ridolfi, L; Ridolfi, R; Ascari-Raccagni, A; Fabbri, M; Casadei, S; Gatti, A; Trevisan, G; Righini, MG
      Intralesional granulocyte-monocyte colony-stimulating factor followed by subcutaneous interleukin-2 in metastatic melanoma: a pilot study in elderly patients

      JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
    46. Bollard, CM; Heslop, HE; Brenner, MK
      Gene-marking studies of hematopoietic cells

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    47. Soos, JM; Krieger, JL; Stuve, O; King, CL; Patarroyo, JC; Aldape, K; Wosik, K; Slavin, AJ; Nelson, PA; Antel, JP; Zamvil, SS
      Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-Cell activation

      GLIA
    48. Kemp, EH; Waterman, EA; Weetman, AP
      Autoimmune aspects of vitiligo

      AUTOIMMUNITY
    49. Van Tendeloo, VFI; Van Broeckhoven, C; Berneman, ZN
      Gene-based cancer vaccines: an ex vivo approach

      LEUKEMIA
    50. Millar, EKA; Beretov, J; Sarris, I; Lee, CS
      Mucinous differentiation in colonic adenocarcinoma is associated with a reduction in tumour-infiltrating lymphocytes

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    51. Ricaniadis, N; Kataki, A; Agnantis, N; Androulakis, G; Karakousis, CP
      Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    52. Tsuda, N; Murayama, K; Ishida, H; Matsunaga, K; Komiya, S; Itoh, K; Yamada, A
      Expression of a newly defined tumor-rejection antigen SART3 in musculoskeletal tumors and induction of HLA class I-restricted cytotoxic T lymphocytesby SART3-derived peptides

      JOURNAL OF ORTHOPAEDIC RESEARCH
    53. Ansell, SM; Stenson, M; Habermann, TM; Jelinek, DF; Witzig, TE
      CD4+T-cell immune response to large B-cell non-Hodgkin's lymphoma predictspatient outcome

      JOURNAL OF CLINICAL ONCOLOGY
    54. Lee, P; Wang, F; Kuniyoshi, J; Rubio, V; Stuges, T; Groshen, S; Gee, C; Lau, R; Jeffery, G; Margolin, K; Marty, V; Weber, J
      Effects of interleukin-12 on the immune response to a multipeptide vaccinefor resected metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    55. Santin, AD; Hermonat, PL; Ravaggi, A; Bellone, S; Roman, JJ; Smith, CV; Pecorelli, S; Radominska-Pandya, A; Cannon, MJ; Parham, GP
      Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    56. Melichar, B; Touskova, M; Tosner, J; Kopecky, O
      The phenotype of ascitic fluid lymphocytes in patients with ovarian carcinoma and other primaries

      ONKOLOGIE
    57. Ye, DF; Xie, X; Lu, WG; Chen, HZ; Cheng, B
      Growth inhibition of interleukin-2 receptor gene-transduced peripheral blood lymphocytes on human ovarian cancer cells

      CHINESE MEDICAL JOURNAL
    58. Kebebew, E; Treseler, PA; Ituarte, PHG; Clark, OH
      Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited

      WORLD JOURNAL OF SURGERY
    59. Wu, RS; Kobie, JJ; Besselsen, DG; Fong, TC; Mack, VD; McEarchern, JA; Akporiaye, ET
      Comparative analysis of IFN-gamma B7.1 and antisense TGF-beta gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    60. Bear, HD; Roberts, J; Cornell, D; Tombes, MB; Kyle, B
      Adoptive immunotherapy of cancer with pharmacologically activated lymph node lymphocytes: a pilot clinical trial

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    61. Thomas, ML; Badwe, RA; Deshpande, RK; Samant, UC; Chiplunkar, SV
      Role of adhesion molecules in recruitment of V delta 1 T cells from the peripheral blood to the tumor tissue of esophageal cancer patients

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    62. Kobayashi, H; Tanaka, Y; Yagi, J; Toma, H; Uchiyama, T
      Gamma/delta T cells provide innate immunity against renal cell carcinoma

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    63. Pandolfino, MC; Labarriere, N; Tessier, MH; Cassidanius, A; Bercegeay, S; Lemarre, P; Dehaut, F; Dreno, B; Jotereau, F
      High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    64. Banat, GA; Christ, O; Cochlovius, B; Pralle, HB; Zoller, M
      Tumour-induced suppression of immune response and its correction

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    65. Check, JH; Nazari, P; Goldberg, J; Yuen, W; Angotti, D
      A model for potential tumor immunotherapy based on knowledge of immune mechanisms responsible for spontaneous abortion

      MEDICAL HYPOTHESES
    66. Sprinzl, GM; Kacani, L; Schrott-Fischer, A; Romani, N; Thumfart, WF
      Dendritic cell vaccines for cancer therapy

      CANCER TREATMENT REVIEWS
    67. Kramer, G; Steiner, GE; Paiha, S; Handisurya, A; Djavan, B; Mallone, R; Marberger, M
      Human accessory cells activate fresh, normal, tumor-distant T lymphocytes but not tumor-infiltrating T lymphocytes to lyse autologous tumor cells in a primary cytotoxic T lymphocyte assay in renal cell carcinoma

      EUROPEAN UROLOGY
    68. Zheng, B; Lam, C; Im, S; Huang, J; Luk, W; Lau, SY; Yau, KS; Wong, CK; Yao, K; Ng, MH
      Distinct tumour specificity and IL-7 requirements of CD56(-) and CD56(+) subsets of human gamma delta T cells

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    69. Siebels, M; Meyer, G; Habicht, A; Meuer, SC; Moebius, U
      Simultaneous ligation of CD5 and CD28 with monoclonal antibodies restores impaired immunostimulatory function in human renal cell carcinoma

      UROLOGICAL RESEARCH
    70. Siemens, DR; Ratliff, TL
      Vaccines in urologic malignancies

      UROLOGICAL RESEARCH
    71. Dolstra, H; Fredrix, H; van der Meer, A; de Witte, T; Figdor, C; van de Wiel-van Kemenade, E
      Immunobiology - TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells

      BONE MARROW TRANSPLANTATION
    72. Hiraki, A; Ono, T; Tanaka, M; Kiura, K; Ueoka, H; Kawai, H; Harada, M; Nakayama, E; Noguchi, Y
      Generation of cytotoxic T lymphocytes against autologous lung cancer cellsresistant to apoptosis

      ANTICANCER RESEARCH
    73. Yamaguchi, Y; Ohta, K; Shimizu, K; Minami, K; Noma, K; Hihara, J; Toge, T
      Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2

      ANTICANCER RESEARCH
    74. Seeley, BM; Barthel, SW; To, WC; Kjaergaard, J; Shu, S; Plautz, GE
      Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 costimulation

      OTOLARYNGOLOGY-HEAD AND NECK SURGERY
    75. Stassar, MJJG; Raddrizzani, L; Hammer, J; Zoller, M
      T-helper cell-response to MHC class II-binding peptides of the renal cell carcinoma-associated antigen RAGE-1

      IMMUNOBIOLOGY
    76. Wroblewski, JM; Bixby, DL; Borowski, C; Yannelli, JR
      Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens

      LUNG CANCER
    77. Safa, MM; Foon, KA
      Adjuvant immunotherapy for melanoma, and colorectal cancers

      SEMINARS IN ONCOLOGY
    78. Santin, AD; Ravaggi, A; Bellone, S; Pecorelli, S; Cannon, M; Parham, GP; Hermonat, PL
      Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR plus T cells compared with lymphocytes from tumor draininglymph nodes and peripheral blood in patients with cancer of the uterine cervix

      GYNECOLOGIC ONCOLOGY
    79. Gravekamp, C
      Tailoring cancer vaccines to the elderly: the importance of suitable mousemodels

      MECHANISMS OF AGEING AND DEVELOPMENT
    80. Cho, YJ; Chang, MS; Park, SH; Kim, HS; Kim, WH
      In situ hybridization of Epstein-Barr virus in tumor cells and tumor-infiltrating lymphocytes of the gastrointestinal tract

      HUMAN PATHOLOGY
    81. McCullough, J
      Cellular engineering for the production of blood components

      TRANSFUSION
    82. Takahashi, K; Saito, S; Kamamura, Y; Katakawa, M; Monden, Y
      Prognostic value of CD4+lymphocytes in pleural cavity of patients with non-small cell lung cancer

      THORAX
    83. Malaguarnera, M; Ferlito, L; Gulizia, G; Di Fazio, I; Pistone, G
      Use of interleukin-2 in advanced renal carcinoma: meta-analysis and reviewof the literature

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    84. Jager, D; Jagar, E; Knuth, A
      Vaccination for malignant melanoma: Recent developments

      ONCOLOGY
    85. Bosboom, WMJ; van den Berg, LH; Mollee, I; Sasker, LD; Jansen, J; Wokke, JHJ; Logtenberg, T
      Sural nerve T-cell receptor V beta gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy

      NEUROLOGY
    86. Rosenberg, SA
      Progress in human tumour immunology and immunotherapy

      NATURE
    87. Zeng, G; Wang, X; Robbins, PF; Rosenberg, SA; Wang, RF
      CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    88. Todo, T; Martuza, RL; Rabkin, SD; Johnson, PA
      Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    89. Pantuck, AJ; Zisman, A; Belldegrun, AS
      The changing natural history of renal cell carcinoma

      JOURNAL OF UROLOGY
    90. Inoue, Y; Takaue, Y; Takei, M; Kato, K; Kanai, S; Harada, Y; Tobisu, K; Noguchi, M; Kakizoe, T; Itoh, K; Wakasugi, H
      Induction of tumor specific cytotoxic T lymphocytes in prostate cancer using prostatic acid phosphatase derived HLA-A2402 binding peptide

      JOURNAL OF UROLOGY
    91. Chin, CS; Graham, LJ; Hamad, GG; George, KR; Bear, HD
      Bryostatin/ionomycin-activated T cells mediate regression of established tumors

      JOURNAL OF SURGICAL RESEARCH
    92. Anastassiou, G; Coupland, SE; Stang, A; Boeloeni, R; Schilling, H; Bornfeld, N
      Expression of Fas and Fas ligand in uveal melanoma: biological implicationand prognostic value

      JOURNAL OF PATHOLOGY
    93. Proescholdt, MA; Merrill, MJ; Ikejiri, B; Walbridge, S; Akbasak, A; Jacobson, S; Oldfield, EH
      Site-specific immune response to implanted gliomas

      JOURNAL OF NEUROSURGERY
    94. Doytchinova, IA; Flower, DR
      Toward the quantitative prediction of T-cell epitopes: CoMFA and CoMSIA studies of peptides with affinity for the class I MHC molecule HLA-A*0201

      JOURNAL OF MEDICINAL CHEMISTRY
    95. Mullins, DW; Bullock, TNJ; Colella, TA; Robila, VV; Engelhard, VH
      Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice

      JOURNAL OF IMMUNOLOGY
    96. Sliz, P; Michielin, O; Cerottini, JC; Luescher, I; Romero, P; Karplus, M; Wiley, DC
      Crystal structures of two closely related but antigenically distinct HLA-A2/Melanocyte-Melanoma tumor-antigen peptide complexes

      JOURNAL OF IMMUNOLOGY
    97. Malmberg, KJ; Arulampalam, V; Ichihara, F; Petersson, M; Seki, K; Andersson, T; Lenkei, R; Masucci, G; Pettersson, S; Kiessling, R
      Inhibition of activated/memory (CD45RO(+)) T cells by oxidative stress associated with block of NF-kappa B activation

      JOURNAL OF IMMUNOLOGY
    98. Kurnick, JT; Ramirez-Montagut, T; Boyle, LA; Andrews, DM; Pandolfi, F; Durda, PJ; Butera, D; Dunn, IS; Benson, EM; Gobin, SJP; van den Elsen, PJ
      A novel autocrine pathway of tumor escape from immune recognition: Melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage Melan-A/MART-1 antigen through down-modulation of its promoter

      JOURNAL OF IMMUNOLOGY
    99. Le, HN; Lee, NC; Tsung, K; Norton, JA
      Pre-existing tumor-sensitized T cells are essential for eradication of established tumors by IL-12 and cyclophosphamide plus IL-12

      JOURNAL OF IMMUNOLOGY
    100. Liu, K; Rosenberg, SA
      Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity

      JOURNAL OF IMMUNOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 01:56:52